{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:33:47Z","timestamp":1789659227336,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021801","name":"Prinses M\u00e1xima Centrum voor kinderoncologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004786","name":"ODAS Stichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020692","name":"Memphis Research Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bneo.2024.100060","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T21:18:37Z","timestamp":1732828717000},"page":"100060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Loss of p53 impairs death receptor expression and confers resistance to CD19 CAR T-cell therapy in BCP-ALL"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7943-1459","authenticated-orcid":false,"given":"Willem P. J.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7517-6006","authenticated-orcid":false,"given":"No\u00ebl M. M.","family":"Dautzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8423-0182","authenticated-orcid":false,"given":"Linde","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesa","family":"Klenovsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelisa M.","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marliek","family":"van Hoesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorette S.","family":"van Ingen Schenau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reno S.","family":"Bladergroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland P.","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens T.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-0929","authenticated-orcid":false,"given":"Friso G.","family":"Calkoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1107-6513","authenticated-orcid":false,"given":"Frank N.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.bneo.2024.100060_bib1","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1200\/JCO.22.02705","article-title":"Improved outcome for ALL by prolonging therapy for IKZF1 deletion and decreasing therapy for other risk groups","volume":"41","author":"Pieters","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.bneo.2024.100060_bib2","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.2011.34.8144","article-title":"Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia","volume":"29","author":"Hof","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.bneo.2024.100060_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2017.75.5215","article-title":"TP53 germline variations influence the predisposition and prognosis of B-cell acute lymphoblastic leukemia in children","volume":"36","author":"Qian","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2024.100060_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood-2020-142012","article-title":"Distinct prognostic effects of TP53 mutations in newly diagnosed versus relapsed\/refractory (R-R) patients (pts) with B-acute lymphoblastic leukemia (ALL) treated with mini-Hcvd-inotuzumab ozogamicin with or without blinatumomab regimens","volume":"136","author":"Kanagal-Shamanna","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2024.100060_bib5","first-page":"1755","article-title":"Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy","volume":"109","author":"Cox","year":"2024","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bneo.2024.100060_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1200\/JCO.21.02143","article-title":"Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy","volume":"40","author":"Shouval","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.bneo.2024.100060_bib7","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/bloodadvances.2020001466","article-title":"Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.bneo.2024.100060_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s44321-024-00024-2","article-title":"Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells","volume":"16","author":"Mueller","year":"2024","journal-title":"EMBO Mol Med"},{"issue":"7","key":"10.1016\/j.bneo.2024.100060_bib9","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1080\/10428194.2017.1390232","article-title":"Accurate detection of low-level mosaic mutations in pediatric acute lymphoblastic leukemia using single molecule tagging and deep-sequencing","volume":"59","author":"Yu","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.bneo.2024.100060_bib10","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2010-11-320309","article-title":"Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment","volume":"118","author":"Schmitz","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bneo.2024.100060_bib11","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1182\/blood-2016-09-738070","article-title":"Ex\u00a0vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia","volume":"129","author":"Frismantas","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bneo.2024.100060_bib12","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1038\/s41375-020-0831-z","article-title":"Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r\/r B-ALL children","volume":"34","author":"Pan","year":"2020","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.bneo.2024.100060_bib13","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1158\/1078-0432.CCR-21-1559","article-title":"Overcoming intrinsic resistance of cancer cells to CAR T-cell killing","volume":"27","author":"Lemoine","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.bneo.2024.100060_bib14","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.188.11.2033","article-title":"p53 activates the CD95 (APO-1\/Fas) gene in response to DNA damage by anticancer drugs","volume":"188","author":"M\u00fcller","year":"1998","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.bneo.2024.100060_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng1097-141","article-title":"KILLER\/DR5 is a DNA damage-inducible p53-regulated death receptor gene","volume":"17","author":"Wu","year":"1997","journal-title":"Nat Genet"},{"issue":"20","key":"10.1016\/j.bneo.2024.100060_bib16","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1242\/jcs.00739","article-title":"Apoptosis - the p53 network","volume":"116","author":"Haupt","year":"2003","journal-title":"J\u00a0Cell Sci"},{"issue":"9","key":"10.1016\/j.bneo.2024.100060_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.2019002121","article-title":"Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity","volume":"135","author":"Dufva","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bneo.2024.100060_bib18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/2159-8290.CD-19-0813","article-title":"Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T-cell dysfunction","volume":"10","author":"Singh","year":"2020","journal-title":"Cancer Discov"},{"issue":"18","key":"10.1016\/j.bneo.2024.100060_bib19","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1182\/bloodadvances.2022009543","article-title":"Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation","volume":"7","author":"Kim","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.bneo.2024.100060_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41419-023-05829-6","article-title":"Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia","volume":"14","author":"Sugita","year":"2023","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.bneo.2024.100060_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-022-00915-1","article-title":"Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies","volume":"7","author":"Yan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/j.bneo.2024.100060_bib22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41388-022-02196-y","article-title":"Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax","volume":"41","author":"Fidyt","year":"2022","journal-title":"Oncogene"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T02:58:07Z","timestamp":1762657087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328024000608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2950328024000608"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100060","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of p53 impairs death receptor expression and confers resistance to CD19 CAR T-cell therapy in BCP-ALL","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100060"}}